All News from CISION PR Newswire

PR News Thailand x CISION PR Newswire

CISION PR Newswire

CISION PR Newswire - Waterdrop Inc. Releases 2023 Annual Report: Sustai...

BEIJING, April 30, 2024 /PRNewswire/ -- On April 25, 2024, Waterdrop Inc. ("Waterdrop", the "Company...

CISION PR Newswire - Otis Wins Maintenance Portfolio with SMRT Trains, Singapore's Pioneer Rail Operator

CISION PR Newswire - Otis Wins Maintenance Portfolio with SMRT Trains, ...

SINGAPORE, April 30, 2024 /PRNewswire/ -- Otis (NYSE: OTIS), the world's leading manufacturer of ele...

CISION PR Newswire - Qingdao-Germany Economic, Trade, Cultural and Tourism Exchange Meeting Held in Stuttgart, Germany

CISION PR Newswire - Qingdao-Germany Economic, Trade, Cultural and Tour...

QINGDAO, China, April 30, 2024 /PRNewswire/ -- The Qingdao-Germany Economic, Trade, Cultural and Tou...

CISION PR Newswire - Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024

CISION PR Newswire - Dow showcases circular and innovative materials sc...

Partnership with Sealed Air aims to develop more e-commerce packaging with...

CISION PR Newswire - Inspira Enterprise Named a Leader in the 2024 IDC MarketScape Report for Worldwide Emerging MDR Services

CISION PR Newswire - Inspira Enterprise Named a Leader in the 2024 IDC ...

DALLAS, April 30, 2024 /PRNewswire/ -- Inspira Enterprise, Inc. ('Inspira'), a global cybersecurity ...

CISION PR Newswire - Aker Horizons ASA: First-quarter results 2024...

LYSAKER, Norway, April 30, 2024 /PRNewswire/ -- Aker Horizons ASA (OSE: AKH), a developer of green e...

CISION PR Newswire - Gates Foundation to Establish Regional HQ in Moham...

RIYADH, Saudi Arabia, April 30, 2024 /PRNewswire/ -- The Mohammed Bin Salman Foundation "Misk" has e...

CISION PR Newswire - YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

CISION PR Newswire - YS Biopharma Receives Additional 180 Day Extension...

GAITHERSBURG, Md., April 29, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma...

CISION PR Newswire - Technoderma Medicines Advances TDM-180935 Atopic D...

CHENGDU, China, April 29, 2024 /PRNewswire/ -- Technoderma Medicines, Inc. ("the Company"), a clinic...

CISION PR Newswire - SunCar Technology Reports 29% Revenue Growth, Incl...

Adjusted EBITDA increased by $7.2 million to $1.6 million in 2023Conference Call and Webcast on Apri...

Total : 7,817 Posts
1 ... 777 778 779 ... 782
The information provided in this article was created by CISION PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of PR News Thailand.